Articles in the FDA Category
FDA, Headline, Prescription Drugs »
The New York Times reported this week that GlaxoSmithKline, the maker of Avandia, a prescription drug intended for the treatment of Type 2 diabetes, undertook a secret study in 1999 that it has attempted to keep unknown for the past 11 years.
FDA, Prescription Drugs »
The Los Angeles Times reported that the prescription diabetes drug, Avandia, is linked with an increased risk of hearts attacks, heart failure and strokes, as released in two independent recent study findings.
FDA, Prescription Drugs »
Confidential government reports disclosed to the New York Times recommend that the diabetes drug Avandia be removed from the market because of the significant risk of heart attacks and the availability of a safer alternative drug.
FDA, Headline, Litigation, Medical Devices »
![Medtronic Heart Lead Recall Update: “[Sprint] Fidelis lead fracture rate is increasing exponentially with time”](http://www.lieffcabraserblogs.com/injurylaw/wp-content/themes/arthemia/scripts/timthumb.php?src=/images/fidelis.jpg&w=150&h=150&zc=1&q=100)
In March 2009, Medtronic disclosed that at least 13 Sprint Fidelis patients may have died, including four patients whose deaths were related to efforts by doctors to surgically remove the product. In February 2010, the Wall Street Journal reported that the FDA database includes at least 12 additional deaths allegedly linked to the recalled device.
FDA, Prescription Drugs »
Facing evidence of increased risks of stroke and heart attack among patients using high doses of certain anti-anemia drugs, the FDA has announced it will ask outside experts to re-examine the safety and proper dosage of Aranesp, Epogen and Procrit
FDA, Medical Devices »
Two new studies find shortfalls in the Food and Drug Administration’s approval process for heart devices such as pacemakers and stents
FDA, Featured, Prescription Drugs »
Exposure to certain medical dyes used in MRIs has been linked to the development of the debilitating disease Nephrogenic Systemic Fibrosis
FDA, Featured, Prescription Drugs »
The prescription drug Reglan has been linked to Tardive Dyskinesia (TD), a neurological disorder which can include involuntary spasms and movements.
FDA, Prescription Drugs »
The FDA still hasn’t restructured its staff to better monitor drug safety, more than three years after experts recommended key changes in the wake of the Vioxx scandal
FDA, Medical Devices »
The FDA found problems with procedures for preventing and identifying problems with its devices, documenting those problems, and the speed with which it informs the FDA of any issues
